Well done on the glider!
one which will continue moving forward forever
That was the intent.
I do think that we are fortunate to have a route to patients through physicians. Admittedly, the concept is a bit provocative, and there is plenty of snake oil surrounding stem cell research and treatments. Of course, there are a number of people that are willing to be first adopters, but for most people, it is difficult to access the value proposition.
There are some positive results coming to light, such as this MS trial using autologous hematopoetic stem cells (we store HSCs too). As these trials progress, I think the concept will be more generally understood.